Dermatology · Redondo Beach, CA
NPI
1467081091
Since 2020
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
514 N Prospect Ave Ste 103
Redondo Beach, CA, 90277
Phone (310) 937-8555
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$314K
385 prescriptions
Company payments, 2025
$32.34
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Andrea J Borba prescribed most often to Medicare patients was Ketoconazole, with 73 prescriptions and refills. In total Andrea J Borba wrote 385 Medicare prescriptions that cost $314K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-01.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ketoconazole Generic | 73 | 95 | 22 | $1,140 |
| Triamcinolone Acetonide Generic | 33 | 39 | 21 | $546 |
| Fluorouracil Generic | 26 | 26 | 24 | $1,646 |
| Humira Pen Adalimumab | 21 | 21 | Under 11 | $216K |
| Clobetasol Propionate Generic | 20 | 20 | Under 11 | $1,527 |
| Betamethasone Dipropionate Generic | 19 | 25 | Under 11 | $1,005 |
| Mupirocin Generic | 19 | 20 | 18 | $181 |
| Mometasone Furoate Generic | 13 | 13 | Under 11 | $205 |
| Tacrolimus Generic | 13 | 13 | Under 11 | $614 |
| Qbrexza Glycopyrronium Tosylate | 11 | 11 | Under 11 | $8,101 |
| Hydrocortisone Generic | 11 | 17 | Under 11 | $108 |
| Pentoxifylline Generic | 11 | 11 | Under 11 | $104 |
Brand drugs: 69 claims; generic drugs: 316 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrea J Borba $32.34 ($32.34 in general payments such as food, travel and fees) from 1 company. The largest payer was Revance Therapeutics, Inc. with $32.34.
| Company | Payments | Amount |
|---|---|---|
| Revance Therapeutics, Inc. | 1 | $32.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.